Severe, Chronic Pain

Also known as: Chronic Severe Pain / Chronic, severe Pain / Severe Chronic Pain

DrugDrug NameDrug Description
DB00497OxycodoneOxycodone is a semisynthetic derivative of codeine that acts as a narcotic analgesic more potent and addicting than codeine. An extended-release (ER) form of oxycodone (Xtampza ER) was approved for the management of daily, around-the-clock pain management in April, 2016.
DB06204TapentadolOpioid analgesic for treatment of moderate to severe pain. FDA approved on Nov 20, 2008.
DB06283ZiconotideZiconotide (SNX-111; Prialt) is an atypical analgesic agent for the amelioration of severe and chronic pain. Derived from Conus magus (Cone Snail), it is the synthetic form of an ω-conotoxin peptide. In December 2004 the Food and Drug Administration approved ziconotide when delivered as an infusion into the cerebrospinal fluid using an intrathecal pump system.
DrugDrug NamePhaseStatusCount
DB00813FentanylNot AvailableCompleted1
DB01183NaloxoneNot AvailableCompleted1
DB00497OxycodoneNot AvailableCompleted1